Drugs / Docetaxel+Irinotecan+5-FU+LV (1 pat.)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01379482 | Jan 2005 → Mar 2009 | gastric cancer, peritoneal carcinomatosis | Uppsala University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Docetaxel+Irinotecan+5-FU+LV (1 pat.) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01379482 ↗ |
| Route | Intravenous | “i.v. LV” NCT01379482 ↗ |